PHARMACEUTICALS

But while NVIDIA provides accelerated computing, AI frameworks and foundation model infrastructure that make advanced AI possible, Microsoft provides the cloud, data platform, security and enterprise AI environment that enable pharmaceutical companies to deploy those capabilities at scale across the business.

From Azure and Copilot to Fabric and Cloud for Healthcare, Microsoft’ s diverse suite of healthcare-specific and sector-agnostic technologies allows pharmaceutical companies to unify data from R & D, clinical trials, manufacturing, regulatory affairs

and commercial operations, then layer AI capabilities on top.

Microsoft’ s life sciences strategy has accelerated rapidly over the past 18 months. Standout developments include its five-year strategic collaboration with Haleon to scale AI across the consumer health company’ s global operations and news that NHS England plans to roll out Microsoft 365 Copilot to more than 500,000 clinicians and support staff.

Microsoft is evolving from a cloud provider into the AI operating platform for life sciences. Through Azure AI Foundry, Copilot, agentic AI and strategic partnerships with pharmaceutical and healthcare organisations, it is enabling AI adoption across research, clinical development, manufacturing and enterprise operations.

Satya Nadella Chief Executive Officer Microsoft